Holen Sie sich die Stockscreener-App
53.94
2.34%
-1.515
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Universal Beteiligungs und Servicegesellschaft mbH Increases Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen Explores Possible Sale After New Buyer Talks: Report - Benzinga
Takeover rumours at Qiagen fuel share price surge - European Biotechnology Magazine
QIAGEN NV : DZ Bank reaffirms its Buy rating - marketscreener.com
QIAGEN NV : UBS gives a Neutral rating - marketscreener.com
Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock? - Yahoo Finance
QIAGEN NV : Buy rating from Jefferies - marketscreener.com
Qiagen (QGEN) hits 4-year high as earnings loom - MSN
Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth - GlobeNewswire Inc.
Qiagen Said to Weigh Strategic Options Amid Fresh Interest - Bloomberg.com
Qiagen (QGEN) Hits 4-Year High as Earnings Loom - Insider Monkey
Qiagen (NYSE:QGEN) Sets New 52-Week HighStill a Buy? - MarketBeat
QIAGEN’s Q4 2025 Announcement Sparks Market Interest - timothysykes.com
Qiagen (QGEN) Shares Surge Amid Takeover Speculation - GuruFocus
Agilent and Danaher Eye Qiagen Acquisition as Shares Surge 19% - Intellectia AI
Agilent, Danaher could be potential buyers of Qiagenanalyst (QGEN:NYSE) - Seeking Alpha
Qiagen stock price jumps nearly 16% as Bloomberg report revives sale talk - TechStock²
Qiagen gains on report it's weighing options amid takeover interest - MSN
Dutch biotech company soars: Rumors of discussions with potential buyers - medwatch.com
Qiagen (QGEN) Surges 12% Amid Potential Sale Discussions - GuruFocus
Qiagen (QGEN) Evaluates Sale Options Amid Takeover Interest, Shares Up 12% - Intellectia AI
Qiagen weighing strategic options amid fresh takeover interest, Bloomberg reports - Reuters
QIAGEN Stock Poised for Movement Amid Q4 Results Announcement - StocksToTrade
QGEN Stock Rises Amid Potential Sale Discussions - GuruFocus
Qiagen stock soars after report company weighing strategic options By Investing.com - Investing.com UK
Qiagen stock soars after report company weighing strategic options - Investing.com
Qiagen Is Said to Consider Strategic Options Amid Fresh Interest - Bloomberg.com
QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast - sharewise.com
How to listen to QIAGEN’s Q4 2025 earnings webcast on Feb. 5 - Stock Titan
23,093 Shares in Qiagen N.V. $QGEN Purchased by SG Americas Securities LLC - MarketBeat
Qiagen N.V. $QGEN Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Sumitomo Mitsui Trust Group Inc. Invests $7.29 Million in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. (NYSE:QGEN) Short Interest Down 20.2% in December - MarketBeat
Campbell & CO Investment Adviser LLC Makes New Investment in Qiagen N.V. $QGEN - MarketBeat
Analysis Recap: Is Qiagen NV stock a smart retirement pickJuly 2025 Earnings & Safe Capital Investment Plans - baoquankhu1.vn
Qiagen Reports AFM Notification of Major Stake by Massachusetts Financial Services - TipRanks
Massachusetts Financial Services Discloses Nearly 10% Voting Stake in Qiagen - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
Release according to Article 40, Section 1 of the WpHG - TradingView — Track All Markets
QIAGEN NV : Receives a Buy rating from DZ Bank - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Platform Bet on the Future of Medicine - AD HOC NEWS
Qiagen and Gencurix partner for oncology tests - MSN
Did Qiagen’s (QGEN) AI and Automation Push Just Redefine Its Diagnostics Investment Narrative? - simplywall.st
JPM26: Qiagen outlines key priorities to drive momentum in 2026 - Medical Device Network
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - GlobeNewswire
Aug Momentum: How Qiagen NV stock performs in interest rate cycles2025 Big Picture & High Accuracy Swing Entry Alerts - Bộ Nội Vụ
QIAGEN Board Member’s Holdings Adjusted Following Share Consolidation - TipRanks
QIAGEN Adjusts Management Shareholdings Following Synthetic Share Repurchase - TipRanks
QIAGEN Adjusts Board Member Shareholding Following Synthetic Share Consolidation - TipRanks
QIAGEN discloses management share consolidation under synthetic repurchase program - TipRanks
QIAGEN adjusts insider shareholdings after synthetic share repurchase and consolidation - TipRanks
QIAGEN adjusts board member shareholding after synthetic share consolidation - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView — Track All Markets
Qiagen N.V.: Diagnostics Specialist Tests Investor Patience Amid Sideways Trading and Selective Opti - AD HOC NEWS
Qiagen (QGEN) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Solid Profitable Growth - BioSpace
QIAGEN Sets 2026 Priorities to Drive Growth Across Five Pillars Toward Achieving 2028 Goals for Soli - PharmiWeb.com
Qiagen sets 2026 priorities to drive growth - marketscreener.com
Qiagen N.V.: How a Quiet Diagnostics Powerhouse Became a Genomics Infrastructure Play - AD HOC NEWS
Published on: 2026-01-10 23:18:15 - ulpravda.ru
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):